With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The role of immunogenetics in natural killer cell targeting of neuroblastoma||Memorial Sloan-Kettering Cancer Center / Katharine Hsu||Innovation Grants||2008||New York|
|TrkB Signaling in the Genesis of Murine Neuroblastoma||University of Vermont / Rae Nishi, PhD||Innovation Grants||2007||Vermont|
|Establishing surrogate markers of angiogenesis in pediatric oncology phase I and II clinical trials: A Children’s Oncology Group study||Hospital for Sick Children / Sylvain Baruchel, MD||Innovation Grants||2007||Ontario|
|The role of overexpressed microRNA’s in the pediatric cancer rhabdomyosarcoma||University of Pennsylvania / Frederic Barr, MD, PhD||Innovation Grants||2007||Pennsylvania|
|Rac in p190-BCR-ABL0Induced Leukemia.||Cincinnati Children's Hospital Medical Center / Jose Cancelas, MD, PhD||Innovation Grants||2007||Ohio|
|Adoptive immunotherapy using clinical-grade T cells.||University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD||Innovation Grants||2007||Texas|
|Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma||The Pennsylvania State University / Ken Lucas, MD||Innovation Grants||2006||Pennsylvania|
|Tyrosine Kinase Mutation Discovery in Neuroblastoma.||Dana-Farber Cancer Institute / Matthew Meyerson, MD, PhD||Innovation Grants||2006||Massachusetts|
|Molecular characterization of OTX2 as a novel therapeutic target.||Duke University Medical Center / Hai Yan, MD||Innovation Grants||2006||North Carolina|
|Parallel sequencing to identify the causes of childhood cancer.||Baylor College of Medicine / Sharon Plon, MD, PhD||Innovation Grants||2006||Texas|